PT - JOURNAL ARTICLE AU - Guo, Xiaohao AU - Liu, Ziyan AU - Yang, Shiting AU - Zhao, Zeyu AU - Guo, Yichao AU - Abudurusuli, Guzainuer AU - Rui, Jia AU - Wang, Yao AU - Zhao, Shanlu AU - Zeng, Ge AU - Hu, Shixiong AU - Luo, Kaiwei AU - Chen, Tianmu TI - Optimal vaccination with time-varying based on immunity barrier in Hunan Province, China AID - 10.1101/2022.03.02.22271610 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.02.22271610 4099 - http://medrxiv.org/content/early/2022/03/03/2022.03.02.22271610.short 4100 - http://medrxiv.org/content/early/2022/03/03/2022.03.02.22271610.full AB - The current outbreak of novel coronavirus disease 2019 (COVID-19) is already causing a serious disease burden worldwide, this paper analyzed data of a delta variant Covid-19 outbreak in Hunan, China, and proposed an optimal dose-wise dynamical vaccinating process based on local contact pattern and vaccine coverage that minimize the accumulative cases in a certain future time interval. The optimized result requires an immediate vaccination to that none vaccinated at age group 30 to 39, which is coherent to the prevailing strategies. The dose-wise optimal vaccinating process can be directive for countries or regions where vaccines are not abundant. We recommend that vaccination should be further intensified to increase the coverage of booster shots, thus effectively reducing the spread of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Bill & Melinda Gates Foundation (INV-005834), and the Impact on prevention and control COVID-19 of vaccination intention and effectiveness: a modelling study(2021YFC2301604).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors